Dorzagliatin: Clinical Trials

24 trials of Dorzagliatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 13 Phase 1, 4 Phase 2, 3 Not applicable, 3 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 113Completed 11, Recruiting 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Unknown 1
Not applicable3Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 33Completed 2, Active not recruiting 1
Phase 41Completed 1

Follow Dorzagliatin: new trials by email Literature Review of Dorzagliatin trials Research Report on Dorzagliatin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency
Dorzagliatin, Linagliptin - Type 2 Diabetes Mellitus (T2DM), Chronic Renal Insufficiency
Not applicableWithdrawnSun Yat-sen University2026-12-012026-10-16
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
Dorzagliatin, Placebo - Pancreatic Insufficiency, Cystic Fibrosis-related Diabetes
Phase 1RecruitingMichael R. Rickels, MD, MS152025-10-212026-08-31
Glucokinase Activator in Monogenic Diabetes
Dorzagliatin, matched placebo - Diabetes Mellitus, Monogenic Diabetes
Phase 2RecruitingChinese University of Hong Kong442025-04-302026-04-30
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes
Dorzagliatin - Diabetes Mellitus, Prediabetes / Type 2 Diabetes
Not applicableNot yet recruitingElaine Chow302025-04-022025-03-04
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2
Not applicableUnknownYan Bi1062024-02-202024-01-24
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Dorzagliatin tablets - Type2diabetes
Phase 4CompletedHua Medicine Limited20242024-01-172026-07-10
Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT
Dorzagliatin, Placebo - Glucose Intolerance
Phase 1 / Phase 2UnknownChinese University of Hong Kong202022-08-012022-07-25
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
Metformin, Insulin Glargine, Dorzagliatin - Type 2 Diabetes
Phase 3Active not recruitingUniversity of Alabama at Birmingham1002022-03-072025-07-30
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
Dorzagliatin, placebo - Diabetes Mellitus, Type 2
Phase 2CompletedChinese University of Hong Kong182020-09-302022-07-22
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
HMS5552 - Type 2 Diabetes Mellitus
Phase 1CompletedHua Medicine Limited172019-04-232020-03-27
Drug Interaction Study Between Dorzagliatin and Empagliflozin
Empagliflozin, Dorzagliatin - Patients
Phase 1CompletedHua Medicine Limited162019-04-182025-03-24
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
HMS5552 - Type 2 Diabetes Mellitus
Phase 1CompletedHua Medicine Limited252019-02-182022-11-29
Drug Interaction Study Between Dorzagliatin and Sitagliptin
Sitagliptin, Dorzagliatin - Patients
Phase 1CompletedHua Medicine Limited152019-01-312023-02-28
The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus
HMS5552 - Type2 Diabetes Mellitus
UnknownMajianhua242018-12-122021-08-26
DDI Study Between Dorzagliatin and Rifampicin
Dorzagliatin - Drug Interaction
Phase 1CompletedHua Medicine Limited152018-03-272019-09-06
Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
HMS5552, Placebo - Diabetes Mellitus, Type 2
Phase 3CompletedHua Medicine Limited7672017-10-152021-08-26
DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
Dorzagliatin - Drug Interaction
Phase 1CompletedHua Medicine Limited182017-10-132019-09-06
Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
HMS5552, Placebo - Diabetes Mellitus, Type 2
Phase 3CompletedHua Medicine Limited4632017-07-182021-08-26
Human Mass Balance Study of HMS5552 in Healthy Subjects
HMS5552 - Healthy Subject
Phase 1CompletedHua Medicine Limited62017-03-292018-12-31
Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Metformin, HMS5552 - Type 2 Diabetes Mellitus
Phase 1CompletedHua Medicine Limited122015-10-012016-02-17

Showing 20 of 24. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (13)  ·  Diabetes Mellitus (2)  ·  Exocrine Pancreatic Insufficiency (1)  ·  Glucose Intolerance (1)  ·  Prediabetic State (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Hua Medicine Limited (15)  ·  Chinese University of Hong Kong (3)  ·  Elaine Chow (1)  ·  Majianhua (1)  ·  Michael R. Rickels, MD, MS (1)  ·  Sun Yat-sen University (1)  ·  University of Alabama at Birmingham (1)  ·  Yan Bi (1)

Countries

China (13)  ·  United States (6)  ·  Hong Kong (3)

Top investigators

Gregory J Tracey, MD (2)  ·  Charles Tomek, MD (1)  ·  Dalong Zhu, MD,PhD (1)  ·  Dalong Zhu, PhD (1)  ·  Elaine Chow, MBChB, PhD, FRCP (1)  ·  Gregory Tracey, MD (1)  ·  Jia Miao, MD (1)  ·  Michael R Rickels, MD, MS (1)  ·  Ping Fu, MD (1)  ·  Wenying Yang, MD (1)  ·  XueNing LI, MD (1)  ·  Yanbing Li (1)

Results publications

PMID 29735394, PMID 34706161, PMID 35551292, PMID 42014686

NIH funding

R01DK029953 (1)